Atlas Trials

Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection

Clinical trial NCT05236387 · TERMINATED

Trial details

NCT number
NCT05236387
Sponsor
Johns Hopkins University
Status
TERMINATED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2022-03-01
Primary completion
2023-05-23
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.